Protein C inhibitor regulates hepatocyte growth factor activator-mediated liver regeneration in mice

Gut

Volumn 57, Issue 3, 2008, Pages 365-373

  Hamada, T ^a   Kamada, H ^a   Hayashi, T ^a   Nishioka, J ^a   Gabazza, E C ^a   Isaji, S ^a   Uemoto, S ^a   Suzuki, Koji ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; AMINOTRANSFERASE; BIOLOGICAL MARKER; CYTOKINE; ENZYME ACTIVATOR; HEPATOCYTE GROWTH FACTOR ACTIVATOR; HYALURONIC ACID; INTERLEUKIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C INHIBITOR ANTIBODY; SCATTER FACTOR; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; GENE EXPRESSION REGULATION; HUMAN; LIVER CONGESTION; LIVER HEMORRHAGE; LIVER INJURY; LIVER REGENERATION; LIVER SINUSOID; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CYTOKINES; GENE EXPRESSION; HEPATECTOMY; HUMANS; LIVER; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; POSTOPERATIVE PERIOD; PROTEIN C INHIBITOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES;

EID: 39649099990     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.130153     Document Type: Article

References (52)

1. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 1989;16:1229-34.
2. Okajima A, Miyazawa K, Kitamura N. Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury. Eur J Biochem 1990;193:375-81.
3. Zarnegar R, DeFrances MC, Kost AP, et al. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991;177:559-65.
4. Tomiya T, Tani M, Yamada S, et al. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. 1992;103:1621-4.
5. Sakon M, Monden M, Gotoh M, et al. Hepatocyte growth factor concentrations after liver resection. Lancet 1992;339:818.
6. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-3.
7. Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989;163:967-73.
8. Pediaditakis P, Lopez-Talavera JC, Peterson B, et al. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001;34:688-93.
9. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;81:414-19.
10. Gomez-Lechon MJ, Castelli J, Guillen I, et al. Effect of hepatocyte growth factor on growth and metabolism of human hepatocytes in primary culture. Hepatology 1995;21:1248-54.
11. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991;88:7001-5.
12. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996;119:591-600.
13. Block GD, Locker J, Bowen WC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF-alpha in a chemically defined (HGM) medium. J Cell Biol 1996;132:1133-49.
14. Phaneuf D, Chen SJ, Wilson JM. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and a protective effect against apoptosis. Mol Med 2000;6:96-103.
15. Schulze-Bergkamen H, Brenner D, Krueger A, et al. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 2004;39:645-54.
16. Shimomura T, Miyazawa K, Komiyama Y, et al. Activation of hepatocyte growth factor by homologous proteases, blood coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995;229:257-61.
17. Miyazawa K, Shimomura T, Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 1996;271:3615-18.
18. Okajima A, Miyazawa K, Naitoh Y, et al. Induction of hepatocyte growth factor activator messenger RNA in the liver following tissue injury and acute inflammation. Hepatology 1997;25:97-102.
19. Shimomura T, Kondo J, Ochiai M, et al. Activation of the zymogen of hepatocyte growth factor activation by thrombin. J Biol Chem 1993;268:22927-32.
20. Miyazawa K, Shimomura T, Naka D, et al. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 1994;269:8966-70.
21. Suzuki K, Nishioka J, Kusumoto H, et al. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 1984;95:187-95.
22. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor: Purification from human plasma and characterization. J Biol Chem 1983;258:163-8.
23. Meijers JCM, Kanters DH, Vlooswijk RA, et al. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988;27:4231-7.
24. Rezaie AR, Cooper ST, Church FC, et al. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995;270:25336-9.
25. Yuasa H, Tanaka H, Hayashi T, et al. Bovine protein C inhibitor has a unique reactive site and can transiently inhibit plasmin. Thromb Haemost 2000;83:262-7.
26. Espana F, Estelles A, Fernandez PJ, et al. Evidence for the regulation of urokinase and tissue plasminogen activators by serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost 1993;70:989- 94.
27. Stief TW, Radtke KP, Heimburger N. Inhibition of urokinase by protein C inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hoppe Seyler 1987;368:1427-33.
28. Espana F, Gilabert J, Estelles A, et al. Functional active protein C inhibitor/ plasminogen activator inhibitor-3(PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991;64:309- 20.
29. Hermans JM, Jones R, Stone SR. Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry 1994;33:5440-4.
30. Uhrin P, Dewerchin M, Hilpert M, et al. Disruption of the protein C inhibitor gene result in impaired spermatogenesis and male infertility. J Clin Invest 2000;106:1531-9.
31. Wakita T, Hayashi T, Nishioka J, et al. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 2004;108:516-23.
32. Suzuki, K. Protein C inhibitor (PAI-3): structure and multi-function. Fibrinol Proteol 2000;14:133-45.
33. Hayashi T, Nishioka J, Kamada H, et al. Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J Thromb Haemost 2004;2:949-61.
34. Hayashi T, Nishioka J, Nakagawa N, et al. Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator. J Thromb Haemost 2007;5:1477-85.
35. Higgins GM, Anderson RM. Experimental pathology of the liver: Restoration of the liver of the white rat following partial removal. Arch Pathol 1931;12:186-202.
36. Vrochides D, Papanikolaou V, Pertoft H, et al. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration. Hepatology 1996;23:1650-5.
37. Itoh H, Kataoka H, Hamasuna R, et al. Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes. Eur J Biochem 2000;267:3351-9.
38. Kataoka H, Shimomura T, Kawaguchi T, et al. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 2000;275:40453- 62.
39. Jensen MR, Factor VM, Thorgeirsson SS. Regulation of cyclin G1 during murine hepatic regeneration following dipin-induced DNA damage. Hepatology 1998;28:537-46.
40. Wustefeld T, Rakemann T, Kubicka S, et al. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 2000;32:514-22.
41. Olle EW, Ren X, McClintoch SD, et al. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology 2006;44:540-9.
42. Kambayashi J, Sakon M, Yokota M, et al. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers. Thromb Res 1990;60:157-67.
43. Shimada M, Matsumata T, Kamekura T, et al. Modulation of coagulation and fibrinolysis in hepatic resection: a randomized prospective control study using antithrombin III concentrates. Thromb Res 1994;74:105-14.
44. Mochida S, Arai M, Ohno A, et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 1999;29:1532-40.
45. Dahlback B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Letters 2005;579:3310-16.
46. Kaido T, Yoshikawa A, Seto S, et al. Pretreatment with soluble thrombomodulin prevents intrasinusoidal coagulation and liver dysfunction following extensive hepatectomy in cirrhotic rats. Thromb Haemost 1999;82:1302-6.
47. Yoshikawa A, Kaido T, Seto S, et al. Activated protein C prevents multiple organ injury following extensive hepatectomy in cirrhotic rats. J Hepatology 2000;33:953-60.
48. Brueckmann M, Hoffmann U, Rossi L, et al. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocyte. Cytokine 2004;26:106-13.
49. Franscini N, Bachli EB, Blau N, et al. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 2004;110:2903-9.
50. Levi M, Dofller-Melly J, Reitsma P, et al. Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood 2003;101:4823-7.
51. Kaibori M, Inoue T, Sakakura Y, et al. Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis. J Surg Res 2002;106:108-14.
52. Yanagida H, Kaibori M, Hijikawa T, et al. Administration of rhHGF-activator via portal vein stimulates the regeneration of cirrhotic liver after partial hepatectomy in rats. J Surg Res 2006;130:38-44.